Harbin Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2012: 0.97%

Harbin Pharmaceutical Group Co Ltd (600664) has an Asset Resilience Ratio of 0.97% as of September 2012. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Harbin Pharmaceutical Group Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥150.00 Million

≈ $21.95 Million USD Cash + Short-term Investments

Total Assets

CN¥15.40 Billion

≈ $2.25 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1993–2006)

This chart shows how Harbin Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. See what is Harbin Pharmaceutical Group Co Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Harbin Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Harbin Pharmaceutical Group Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥150.00 Million	0.97%
Total Liquid Assets	CN¥150.00 Million	0.97%

Asset Resilience Insights

Limited Liquidity: Harbin Pharmaceutical Group Co Ltd maintains only 0.97% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Harbin Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Harbin Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
KPC Pharmaceuticals Inc SHG:600422	Drug Manufacturers - Specialty & Generic	16.37%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Cheng Du Sheng Nuo Biotec Co. Ltd. A SHG:688117	Drug Manufacturers - Specialty & Generic	3.51%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	5.72%

Annual Asset Resilience Ratio for Harbin Pharmaceutical Group Co Ltd (1993–2006)

The table below shows the annual Asset Resilience Ratio data for Harbin Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2006-12-31	0.02%	CN¥2.00 Million ≈ $292.85K	CN¥9.40 Billion ≈ $1.37 Billion	+0.02pp
2003-12-31	0.00%	CN¥52.00K ≈ $7.61K	CN¥6.58 Billion ≈ $962.60 Million	0.00pp
2002-12-31	0.00%	CN¥59.00K ≈ $8.63K	CN¥5.95 Billion ≈ $871.18 Million	0.00pp
2001-12-31	0.00%	CN¥224.00K ≈ $32.78K	CN¥5.77 Billion ≈ $843.79 Million	-0.01pp
2000-12-31	0.01%	CN¥436.00K ≈ $63.80K	CN¥4.45 Billion ≈ $651.09 Million	-0.01pp
1997-12-31	0.02%	CN¥462.10K ≈ $67.62K	CN¥2.90 Billion ≈ $424.54 Million	-0.01pp
1996-12-31	0.02%	CN¥582.32K ≈ $85.21K	CN¥2.49 Billion ≈ $364.10 Million	-0.05pp
1995-12-31	0.07%	CN¥1.79 Million ≈ $262.10K	CN¥2.40 Billion ≈ $350.93 Million	-0.16pp
1994-12-31	0.24%	CN¥5.60 Million ≈ $819.31K	CN¥2.35 Billion ≈ $343.55 Million	-0.04pp
1993-12-31	0.28%	CN¥6.30 Million ≈ $922.28K	CN¥2.24 Billion ≈ $327.42 Million	--

pp = percentage points

About Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.39 Billion

CN¥9.47 Billion CNY

Market Cap Rank

#7785 Global

#1957 in China

Share Price

CN¥3.76

Change (1 day)

+2.73%

52-Week Range

CN¥3.23 - CN¥4.44

All Time High

CN¥8.34